DIO Corporation (KOSDAQ:039840)
15,810
-100 (-0.63%)
Jan 19, 2026, 3:30 PM KST
DIO Corporation Market Cap
DIO Corporation has a market cap or net worth of 211.68 billion as of January 16, 2026. Its market cap has decreased by -9.84% in one year.
Market Cap
211.68B
Enterprise Value
248.16B
Revenue
155.15B
Ranking
n/a
PE Ratio
35.97
Stock Price
15,810.00
Market Cap Chart
Since March 1, 2001, DIO Corporation's market cap has increased from 25.42B to 211.68B, an increase of 732.68%. That is a compound annual growth rate of 8.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 213.02B | -5.80% |
| Dec 30, 2025 | 226.14B | 1.27% |
| Dec 30, 2024 | 223.31B | -31.36% |
| Dec 28, 2023 | 325.35B | 11.83% |
| Dec 29, 2022 | 290.93B | -47.39% |
| Dec 30, 2021 | 553.05B | 17.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 88.92T |
| Celltrion | 45.18T |
| ALTEOGEN | 26.53T |
| ABL Bio | 10.84T |
| SK Biopharmaceuticals | 9.26T |
| Yuhan | 7.91T |
| HLB Co., Ltd. | 6.83T |
| Sam Chun Dang Pharm. | 6.43T |